ARWR - Arrowhead Pharmaceuticals Q4 2023 Earnings Preview
2023-11-28 17:35:34 ET
More on Arrowhead Pharmaceuticals
- Arrowhead Pharmaceuticals: A High-Risk, High-Reward Bet
- GSK inks $1B deal to obtain rights to hepatitis B drug from J&J
- Ionis late-stage rare disease data fails to impress Bernstein
- Seeking Alpha’s Quant Rating on Arrowhead Pharmaceuticals
- Historical earnings data for Arrowhead Pharmaceuticals
For further details see:
Arrowhead Pharmaceuticals Q4 2023 Earnings Preview